Magda Schaler-Haynes serves as Senior Advisor at the New Jersey Office of the Attorney General, based in the Division of Consumer Affairs which houses over 51 professional licensing boards that regulate the majority of New Jersey's healthcare professions. There she leads initiatives to advance modernized, evidence-based regulation focusing on COVID-19 emergency response; health equity and anti-discrimination; scopes of practice; provider supply; consumer protection; telehealth; maternal and reproductive health; sexual misconduct; and end of life care. She previously served as the Director of Policy and Strategic Planning at the New Jersey Department of Health, where she oversaw the Department's broad policy portfolio, strategic planning efforts, the Office of Health Information Technology, the Office of Vital Statistics and Records and several councils and commissions. Prior to her appointment, she led the Health Care Transition Team for New Jersey Governor-Elect Phil Murphy. Previously, as an independent consultant, Schaler-Haynes provided strategic services on high stakes policy issues ranging from healthcare price transparency to amicus briefing management in Whole Woman's Health v. Hellerstedt, the Center for Reproductive Rights' successful U.S. Supreme Court challenge of Texas' abortion clinic shut down law. Until 2015, Schaler-Haynes served on the staff of U.S. Senator Robert Menendez (D-NJ) as Special Advisor for healthcare and women's issues. She served as Senior Health Policy Advisor at the New York State Insurance Department until 2011 where she managed health reform activities related to New York's initial insurance exchange establishment, expanded state health insurance rate review, and pursued multi-agency policy initiatives promoting access to healthcare. Magda began her career as an associate in the Health Care Department at the Proskauer firm in New York. Adjunct faculty at Columbia since 2008, Schaler-Haynes' academic interests focus on intersections between constitutional law and health policy. Her courses include: Public Health Law; Money, Politics and Law: Abortion and Public Health; and Reproductive Rights and Practices (with Professor Carol Sanger).
JD, 2001, Columbia Law School
MPH, 1998, Columbia University School of Public Health
BA, 1996, Brandeis University
Member, Federation of State Medical Boards Workgroup on Diversity, Equity and Inclusion in Medical Regulation
Member, Curriculum Committee on Health Law, Mailman School of Public Health, Columbia University, 2010-2011
Member, Honor Code Revision Committee, Mailman School of Public Health, Columbia University, 2008-2009
Honors & Awards
John M. Olin Law and Economics Junior Fellow, Columbia Law School,1999-2000
Humane Studies Fellow, 1998-1999
Areas of Expertise
Gender Bias, Underserved Populations, Women's Health, Federal and State Relations, Health Law, Healthcare Industry, Healthcare Insurance, Healthcare Policy, Healthcare Providers, Healthcare Reform, Healthcare Regulation, Healthcare Workers, Public Health Infrastructure, State and Local Reform Models, Uninsured, Abortion, Contraception, Maternal Health, Reproductive Rights
Select Urban Health Activities
Member, Health Law Committee, Association of the Bar of the City of New York, 2006-2009
Member Ex-Officio, Health Care Cost Containment Subcommittee, Public Health Committee, New York State Bar Association, 2008-2009
Select Global Activities
Magda Schaler-Haynes, Book Review, (reviewing Carol Sanger, About Abortion: Terminating Pregnancy in Twenty-First-Century America) 43 J HEALTH POLIT POLICY LAW 6 (2018).
Schaler-Haynes M. All Payer Claims Databases: Issues and Opportunities for Health Care Cost Transparency in New Jersey. Rutgers Center for State Health Policy Policy Brief (2013).
Schaler-Haynes M, Chesnokova A, Cox C, Feinstein M, Sussex A, Harris J. Abortion Coverage and Health Reform: Restrictions and Options for Exchange-Based Insurance Markets. 15 University of Pennsylvania Journal of Law and Social Change 324 (2012).
Oechsner TJ & Schaler-Haynes M. Keeping it Simple: Health Plan Benefit Standardization and Regulatory Choice Under the Affordable Care Act. 74 Albany Law Review 241 (2011).